Cingulate logo

Cingulate Share Price (NASDAQ: CING)

$3.97

0.03

(0.76%)

Last updated on

Check the interactive Cingulate Stock chart to analyse performance

Cingulate stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$3.95
    Today's High:$4.03

    Day's Volatility :1.99%

  • 52 Weeks Low:$3.02
    52 Weeks High:$9.69

    52 Weeks Volatility :68.83%

Cingulate Stock Returns

PeriodCingulate IncIndex (Russel 2000)
3 Months
-0.25%
0.0%
6 Months
0.51%
0.0%
1 Year
-43.29%
0.0%
3 Years
-98.93%
-4.1%

Cingulate Inc Key Stats

Check Cingulate key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$3.94
Open
$4.02
Today's High
$4.03
Today's Low
$3.95
Market Capitalization
$21.3M
Today's Volume
$79.6K
52 Week High
$9.69
52 Week Low
$3.02
Revenue TTM
$0.0
EBITDA
$-17.2M
Earnings Per Share (EPS)
$135.02
PE Ratio
0.03
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-417.77%

Stock Returns calculator for Cingulate Stock including INR - Dollar returns

The Cingulate stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cingulate investment value today

Current value as on today

₹61,998

Returns

₹38,002

(-38%)

Returns from Cingulate Stock

₹43,286 (-43.29%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Cingulate Stock

-27%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Cingulate Stock from India on INDmoney has decreased by -27% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Cingulate Inc

  • Name

    Holdings %

Analyst Recommendation on Cingulate Stock

Rating
Trend

Buy

    70%Buy

    30%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Cingulate(by analysts ranked 0 to 5 stars)

Cingulate Share Price Target

What analysts predicted

Upside of 598.07%

Target:

$27.71

Current:

$3.97

Cingulate share price target is $27.71, a slight Upside of 598.07% compared to current price of $3.97 as per analysts' prediction.

Cingulate Stock Insights

  • Price Movement

    In the last 1 month, CING stock has moved down by -23.4%
  • CING vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 119.6%
  • CING vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 215.0%

Cingulate Technicals Summary

Sell

Neutral

Buy

Cingulate is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Cingulate Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Cingulate Inc logo
-22.16%
0.51%
-43.29%
-98.93%
-99.63%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About Cingulate Inc

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company develops medications capable of once-daily dosing using its proprietary drug delivery platform technology, Precision Timed Release. Its drug candidates include CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials, as well as CTx-1302 (dextroamphetamine), which is in Phase 1/2 clinical pharmacology and Phase 3 clinical efficacy and safety trials for the treatment of ADHD in children, adolescents, and adults; and CTx-2103 (buspirone) that is in a formulation stage for the treatment of anxiety and related disorders. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.
Organization
Cingulate
Employees
13
CEO
Dr. Shane J. Schaffer Pharm.D.
Industry
Miscellaneous

Key Management of Cingulate Inc

NameTitle
Mr. John A. Roberts M.B.A.
Executive Chairman
Dr. Shane J. Schaffer Pharm.D.
Co-Founder, CEO & Chairman of the Board (Leave of Absence)
Dr. Raul R. Silva M.D.
Co-Founder, Executive VP & Chief Science Officer
Dr. Matthew N. Brams M.D.
Co-Founder, Executive VP & Chief Medical Officer
Thomas Dalton
Vice President of Investor & Public Relations
Mr. Nilay Patel J.D.
Chief Legal Officer

Important FAQs about investing in CING Stock from India :

What is Cingulate share price today?

Cingulate share price today is $3.97 as on at the close of the market. Cingulate share today touched a day high of $4.03 and a low of $3.95.

What is the 52 week high and 52 week low for Cingulate share?

Cingulate share touched a 52 week high of $9.69 and a 52 week low of $3.02. Cingulate stock price today i.e. is closed at $3.97, lower by 59.03% versus the 52 week high.

How to invest in Cingulate Stock (CING) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cingulate on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cingulate Shares that will get you 0.3778 shares as per Cingulate share price of $3.97 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Cingulate Stock (CING) from India?

Indian investors can start investing in Cingulate (CING) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Cingulate stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Cingulate share’s latest price of $3.97 as on August 30, 2025 at 1:29 am IST, you will get 2.5189 shares of Cingulate. Learn more about fractional shares .

What are the returns that Cingulate has given to Indian investors in the last 5 years?

Cingulate stock has given -99.63% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?